News from sponsors
2018 is an exciting year for Thea Pharmaceuticals UK as we celebrate our 10 year anniversary supporting the UK with our continued investment in education and innovation. Our continued aim is to bring the most advanced formulations in eye care, offer true patient benefits and unique preservative free products.
2018 brings not only the opportunity to celebrate 10 years supporting the UK market, we are also moving to a new larger offices as our team grows and launching new and innovative solutions for ophthalmology, whilst supporting our portfolio of products which help alleviate Dry Eye, Blepharitis and Meibomian Gland Dysfunction, along with a range of Eye Nutritionals to support eye health and help to protect vision.
• Thealoz Duo – Thea’s most advanced preservative-free combination of Sodium Hyaluronate and Trehalose - for lubrication, hydration and protection of all dry eyes. Preservative free and suitable for contact lens wearers.
• Hyabak – Preservative-free Sodium Hyaluronate dry eye drops that provide a hydrating and lubricating solution for eyes and contact lenses.
• Blepha range is the No1 lid care range in Europe offers daily gentle lid cleansing that is free from preservatives, perfumes and parabens – plus no rinsing is required as they do not contain soap.
• Eye Nutritionals – Nutrof Total is a TOTAL formula for eye health and vision in once a day capsule, now with added Vitamin D
For more information on our products, training and literature packages please come and see us on our stand at the main entrance, visit our website www.thea-pharmaceuticals.co.uk
CooperVision - Digital Eye Fatigue - What 90% of your patients are not telling you
Seven in ten adults are now experiencing digital eye fatigue1, yet the widespread condition is often dismissed as “normal” by a population increasingly dedicated to their digital devices2,3,4. A combination of everyday factors, including longer periods of digital device use, plus extended exposure to bright light and screen glare, can contribute to digital eye fatigue2. Eye care practitioners and their colleagues are well-placed to understand the impact digital devices are having on the vision and ocular comfort of their patients, as well as provide suitable advice and management regimes. However, research shows that almost 90% of patients do not talk with their eye care practitioners about their interactions with digital devices5.
This discussion workshop introduces four film-based patient and practitioner scenarios allowing candidates to consider how best to understand their patients’ digital lifestyles and consider suitable diagnostic tests. They will also discuss possible ocular complications and considerations as well as confer appropriate advice and management options that are available for a range of patient types and preferences today.
Visit the CooperVision stand at Optometry Tomorrow 2018 or join us at our CET discussion workshop, Digital Eye Fatigue to find out more.
1 “Symptoms associated with eye fatigue in soft contact lens wearers.” Authors: D. Meyer, S. Huenink, M. Rickert, P. Chamberlain, and P. Kollbaum. Presented at the American Academy of Optometry Annual Meeting, October 2015, New Orleans, LA, USA.
2 The Vision Council. Eyes Overexposed: The Digital Device Dilemma - 2016 Digital Eye Strain Report.
3 “Doctor, My Eyes… Are Tired!” Review of Optometry, May 15, 2016.
4 The Vision Council. DigitEYEzed: The Daily Impact of Digital Screens on the Eye Health of Americans - 2014 Digital Eye Strain Report.
5 The Vision Council. Hindsight is 20/20/20: protect your eyes from digital devices: 2015 Digital Eye Strain Report.
Johnson & Johnson Vision is committed to improving and restoring sight for patients worldwide. Since debuting the world’s first disposable soft contact lens in 1987, it has been helping patients see better through their world-leading ACUVUE® Brand Contact Lenses portfolio. In 2017, Johnson & Johnson invested further in eye health by expanding into cataract surgery, laser refractive surgery (LASIK), consumer eye health and the diagnosis and treatment of dry eye. Serving more than 60 million patients a day across 103 countries, Johnson & Johnson Vision is committed to helping more people in more places improve or restore their sight.
Supporting further education for eye care professionals is key in making this commitment a reality. Johnson & Johnson Vision is delighted to once again be a Gold Sponsor of Optometry Tomorrow and bring you two interactive, multi-station discussion workshops: ‘Multifocal Contact Lenses – Getting it Right the First Time!’ and ‘Creating a Stable World for your Astigmats!’. Book your place now.
Only Optos ultra-widefield technology can capture a 200° view (or 82%) of the retina in a single, high resolution optomap® image in less than ½ second. optomap provides 3-in-1 Colour Depth Imaging™: colour, sensory (red free) and choroidal, along with autofluorescence imaging. A larger field of view of the retina uncovers more clinical information which facilitates the early detection, management and effective treatment of disorders and diseases such as retinal detachments and tears, glaucoma, diabetic retinopathy and age-related macular degeneration. Ultra-widefield retinal imaging can also indicate evidence of non-eye or systemic diseases such as hypertension and certain cancers. 400+ published and ongoing clinical trials as well as thousands of customer case studies and testimonials support it’s long term value; optomap is the only clinically validated ultra-widefield imaging technology in the industry, therefore helping eyecare professionals save sight and save lives.
Visit our stand or CET session to:
- Learn how optomap can help differentiate your business
- Learn how routine use of optomap can improve and increase patient throughput and potentially create an additional revenue stream
- Take advantage of a free, no obligation demo in your practice so you and your patients can experience the optomap 'WOW' factor.
- There are several financing options which make owning a new Daytona plus more affordable than ever.
- Collect your free Diagnostic Atlas Booklet, colour and autofluorescence.
More than 35 years successfully developing and manufacturing contact lens care solutions and ocular health products
Avizor is a global leader in supplying products for the cleaning and maintenance of all types of contact lenses along with an ocular health range. Launched in 1981 as a family owned business with its headquarters and production centre in Madrid, Spain, the company started with the production of private label products but soon launched its own Avizor brand.
In the nearly four decades that followed the original launch, the company currently stands in a frontline position to emerge as a global force in the eye care industry. Currently the company exports close to 90% of its production to more than 70 countries, and employs more than 170 people around the world.
Since 1945 Alcon® has been working to enhance quality of life by helping people see better. After merging with CIBA VISION® in 2011, Alcon® became the second largest division of the Novartis® Group. Alcon® is a global leader in eye care and is comprised of two business units – Vision Care and Surgical. Alcon® offer the widest spectrum of eye care products in the world: From a comprehensive portfolio of contact lenses and lens care products to the most complete line of ophthalmic surgical products.
We offer products that improve patients’ vision and match today’s active lifestyles and demands. The Alcon® product portfolio comprises:
- DAILIES® disposable contact lenses, including DAILIES TOTAL1® (the first water gradient contact lens), AOP Product of the Year DAILIES TOTAL1® Multifocal, and DAILIES® AquaComfort Plus® family of contact lenses
- AIR OPTIX® contact lenses, including AIR OPTIX® plus HydraGlyde®
- FreshLook® colour contact lenses
- Lens care products which include OPTI-FREE® PureMoist® multi-purpose disinfecting solution and AOSEPT® PLUS with HydraGlyde®
From high oxygen transmissibility to highly innovative wetting technologies, Alcon® Vision Care continues to set new standards, advancing the science of contact lenses, lens care and state-of-the art manufacturing.
Please visit us at our stand or at www.myalcon.co.uk for more details.
Reflex Colours bring a new dimension to realistic colour matching, with the facility to create as many options as there are people in the world.
Available as a three monthly hydrogel lens in single vision, toric, multifocal and toric multifocal, the Reflex Colours fitting set contains 21 basic colours, four under-punts, plus a limbal ring which can be produced in any of the colours, as Katie Harrop, No7 Professional Services Manager, explains:
“We can also make star bursts in any colour, and the colours can be overlaid in any order and combination. This is going to be of great value to any practices specialising in lenses as they can be used for a very realistic colour change. The great thing is that this is very reproducible as we can overlay and build up colour to create customised combinations. The value of this is not just for therapeutic use but also for a very realistic colour change.”
Significantly cheaper than a hand-painted lens the application is perfect for patients who are post-injury, post disease or have congenital issues.
The patented pad printing process works in much the same way as printing on golf balls, or other curved surfaces, via a “cliché” which transfers the pattern.
The Scope portfolio of products, devices and services now incorporates TearLab, the only validated tear osmolarity meter on the UK market today. Measuring tear film osmolarity, serves as an objective and quantitative global indicator of DED, independent of its etiology (whether it’s aqueous or evaporative). Used in conjunction with a symptomology questionnaire, as recommended by DEWS II, it can provide you with precise and accurate laboratory results at the point-of-care. It has been proven as one of the earliest markers in the self-perpetuating cycle of dry eye disease. The TearLab osmolarity system demonstrates a positive predictive value of 89%, an unparalleled score when compared to other standard DED diagnostic tests also recommended in the DEWS II Report.
 Lemp MA, Bron AJ, Baudouin C, et al. Tear osmolarity in the diagnosis and management of dry eye disease. Am J Ophthalmol. 2011;151:792 e1–798 e1.
 Tomlinson A. Tear film osmolarity: determination of a referent for dry eye diagnosis, Invest Ophthalmol Vis Sci. 2006 Oct; 47 (10); 4309-15.
Introducing the new ZEISS CLARUS 500 - the next generation high-definition ultra-widefield (HD UWF) fundus imaging system.
CLARUS 500 is the first fundus camera that combines true colour with high-resolution clarity down to 7 microns in an Ultra-Widefield view from the macula to the far periphery. The system produces exceptional images in true colour that closely resemble the colour of the retina, as seen through direct observation during clinical examination.
In addition to true colour imaging, CLARUS 500 also captures high resolution fundus autofluorescence (FAF) images–FAF-Blue and FAF-Green–and Infrared (IR) and external eye images. What’s more, the ultra-wide image allows for detection of even subtle diseases in the periphery of the retina.
For efficient multi-modality analysis, CLARUS integrates with ZEISS FORUM® and Retina Workplace for review with other ophthalmic images and exam data.
ZEISS CLARUS 500 has also been purposefully designed to optimize each patient's experience. By bringing the optics to the patient, the system helps create a comfortable patient experience that provides images free of obstructions, such as lids and lashes, and requires fewer recaptures. The live IR preview feature also allows the operator to optimise alignment before capturing an image.
Visit www.zeiss.com/clarus to learn more.